ASTHMA IN AIRCREW: ASSESSMENT, TREATMENT AND DISPOSITION

PDF

Authors
  1. Gray, G.W.
Corporate Authors
Defence and Civil Inst of Environmental Medicine, Downsview ONT (CAN)
Abstract
Asthma represents a spectrum of increased airway reactivity from mildly increased responsiveness through to severe life-threatening bronchospasm. Rational recommendations for treatment and aeromedical disposition require a careful assessment of bronchial reactivity through correlation of the clinical findings with results of pulmonary function testing including an objective measure of airway reactivity. Airway challenge testing with methacholine allows a safe, objective assessment of airway reactivity. In the Canadian Forces, aircrew candidates with a history of wheezing, recurrent cough or bronchitis in childhood, or abnormal screening PFTs are further screened with an airway challenge test. Applicants with a PC20 less than 4 mg/ml are disqualified from pilot selection, and less than 2 mg/ml from other aircrew.
Report Number
AGARD-CP-518-PAP-34 — @Paper presented at the AGARD Aerospace Medical Panel Symposium, Rome, Italy, 21-25 October 1991; CONTAINED IN 92-03430
Date of publication
15 Apr 1992
Number of Pages
6
DSTKIM No
92-03428
CANDIS No
125867
Format(s):
Hardcopy;Document Image stored on Optical Disk

Permanent link

Document 1 of 1

Date modified: